442 results on '"Lannin, Donald"'
Search Results
2. AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers
3. Association of Medicaid Expansion with Post-mastectomy Reconstruction Rates
4. Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
5. Apocrine Breast Cancer: Unique Features of a Predominantly Triple-Negative Breast Cancer
6. Assessing Interobserver Variability of Cosmetic Outcome Assessment in Breast Cancer Patients Undergoing Breast-Conservation Surgery
7. Characteristics and Long-Term Risk of Breast Angiosarcoma
8. ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers
9. Surgical Outcomes of Mastectomy with Immediate Autologous Reconstruction Followed by Radiation
10. Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
11. ASO Visual Abstract: Association of Medicaid Expansion on Postmastectomy Reconstruction Rates
12. Patient-Reported Outcomes and Cosmesis in a Feasibility Study of 4-Dimensional Simulated Image Guided Accelerated Partial Breast Irradiation
13. Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?
14. ASO Author Reflections: Despite Medicaid Expansion, Large Disparities in Breast Reconstruction Persist
15. ASO Author Reflections: Breast Angiosarcoma—A Rare Disease with a Lot of Uncertainty
16. The impact of communication style on patient satisfaction
17. ASO Visual Abstract: Assessing Interobserver Variability of Cosmetic Outcome Assessment in Breast Cancer Patients Undergoing Breast Conservation Surgery
18. ASO Author Reflections: An Evolving Approach to Autologous Reconstruction in the Setting of Postmastectomy Radiation
19. Treatment Intensity for Mammographically Detected Tumors: An Alternative Viewpoint
20. Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer
21. supplemental Figures 1-5 from PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
22. Supplemental Table 1 from PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
23. Data from PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
24. Supplementary Figure Legends from PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
25. CCR Translation for This Article from Cytoplasmic Estrogen Receptor in Breast Cancer
26. Supplementary Table 1 from Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
27. Supplementary Figures 1 - 7 from Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
28. Supplementary Table 2 from Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
29. Breast cancer biology varies by method of detection and may contribute to overdiagnosis
30. Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database
31. Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
32. Racial Differences in Utilization of Breast Conservation Surgery: Results from the National Cancer Data Base (NCDB)
33. Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial
34. Characteristics of Multifocal and Multicentric Breast Cancers
35. Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation
36. The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients
37. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?
38. The Number of Lymph Nodes Dissected in Breast Cancer Patients Influences the Accuracy of Prognosis
39. Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers
40. ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers
41. ASO Author Reflections: Despite Medicaid Expansion, Large Disparities in Breast Reconstruction Persist
42. A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
43. Use of Neoadjuvant Chemotherapy for Patients With Stage I to III Breast Cancer in the United States
44. Supplemental Ultrasonography Screening for Women With Dense Breasts
45. The Left Sided Predominance of Breast Cancer is Decreasing
46. Is There a Correlation Between Breast Cancer Molecular Subtype Using Receptors as Surrogates and Mammographic Appearance?
47. Factors Associated with Breast MRI Use: A Population-Based Analysis
48. Risk and Benefits of Screening Mammography
49. Preoperative Chemotherapy Decreases the Need for Re-Excision of Breast Cancers Between 2 and 4 cm Diameter
50. How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.